Thiophenylaminoimidazolines as prostaglandin I2 antagonists

Details for Australian Patent Application No. 2004255338 (hide)

Owner F.Hoffmann-La Roche AG

Inventors Bley, Keith Roger; Jahangir, Alam; Clark, Robin Douglas

Agent Spruson & Ferguson

Pub. Number AU-A-2004255338

PCT Pub. Number WO2005/005394

Priority 60/485,924 09.07.03 US

Filing date 7 July 2004

Wipo publication date 20 January 2005

International Classifications

C07D 211/72 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/4168 (2006.01)

C07D 207/22 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 239/14 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 243/04 (2006.01) Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

C07D 295/08 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/005394 Priority application(s): WO2005/005394

4 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255340-Use of rapamycin and rapamycin derivatives for the treatment of bone loss

2004255334-Waterbone self-crosslinkable polyurethane dispersions and polyurethane: acrylic hybrid dispersions